Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 5/20 | 0.55 |
| ▸ | LPL | P06858 | 4/20 | 0.55 |
| ▸ | ABCG2 | Q9UNQ0 | 8/20 | 0.49 |
| ▸ | MYC | P01106 | 1/20 | 0.44 |
| ▸ | ABCB1 | P08183 | 6/20 | 0.43 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.41 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.41 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.41 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.41 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23384077 | 0.92 | LIPG (0.60) | LIPGLPLABCG2ABCB1DGAT1 | |
| SCHEMBL31463120 | 0.91 | LIPG (0.63) | LIPGLPLABCG2ABCB1DGAT1 | |
| SCHEMBL29730356 | 0.90 | LIPG (0.68) | LIPGLPLDGAT1MAOAMAOB | |
| SCHEMBL16716568 | 0.90 | LIPG (0.68) | LIPGLPLDGAT1MAOAMAOB | |
| SCHEMBL13492088 | 0.90 | LIPG (0.68) | LIPGLPLDGAT1MAOAMAOB | |
| SCHEMBL15783448 | 0.90 | LIPG (0.68) | LIPGLPLDGAT1MAOAMAOB | |
| SCHEMBL23075584 | 0.88 | LIPG (0.71) | LIPGLPLDGAT1MAOAMAOB | |
| SCHEMBL17996253 | 0.88 | LIPG (0.71) | LIPGLPLDGAT1MAOAMAOB | |
| SCHEMBL24534334 | 0.88 | LIPG (0.71) | LIPGLPLDGAT1MAOAMAOB | |
| SCHEMBL22320238 | 0.88 | LIPG (0.71) | LIPGLPLDGAT1MAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9954181-B2 | Hetero-cyclic compound and organic light emitting device comprising the same | LG CHEM, LTD. (KR) | 2018-04-24 | — | — | US | disclosed |
| US-20160233430-A1 | HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME (As Amended) | LG CHEM, LTD. (KR) | 2016-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160233430-A1 | HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME (As Amended) | CRY1, CRY2, PER2 | LIPG 3265/4885LPL 2186/4885ABCG2 3949/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.